GlassScriptPhysician profile
Mckenzie Atkinson
NPI 1235849043
$455.71
in general payments reported to CMS, 2019-2025
11 companies · $75.69 in 2025
The $75.69 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $145 · 2024: $235 · 2025: $75.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.71 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $127.79 | 2023 | Bulkamid |
| Medtronic, INC. | $54.00 | 2025 | |
| Organon LLC | $52.86 | 2023-2024 | Nexplanon |
| Optumhealth Care Solutions, LLC | $48.50 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Shield Therapeutics INC | $45.24 | 2024 | |
| Amgen INC. | $34.09 | 2024 | Evenity, Prolia |
| Biogen, INC. | $26.47 | 2024 | Zurzuvae |
| Pfizer INC. | $21.69 | 2025 | |
| Merck Sharp & Dohme LLC | $15.77 | 2024 | |
| Novo Nordisk INC | $15.48 | 2024 | Wegovy |
| Exeltis, USA INC. | $13.82 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mckenzie Atkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.